Tirzepatide for weight loss – Prefilled Syringes, similar to Mounjaro and Zepbound

• • Same active Ingredient as Mounjaro and Zepbound

  • Helps you feel full faster, longer

  • Our Tirzepatide has been independently tested and verified by an independent European testing lab to be 99.95% pure – an incredibly high level of quality you can trust. Click the link below to view the test results:
    https://janoshik.com/tests/40674-10mg_Tizepatide_YN5FA6BMRUZE

What is Tirzepatide, and how does it work?

Tirzepatide is a novel, investigational, once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for the treatment of type 2 diabetes and obesity. It represents a significant advancement in the field of metabolic medicine due to its dual action on GIP and GLP-1 receptors, which play crucial roles in glucose and weight regulation.

Tirzepatide works by activating both the GIP and GLP-1 receptors, leading to increased insulin secretion, decreased glucagon secretion, slowed gastric emptying, and reduced appetite. This dual action contributes to improved glycemic control and weight loss in individuals with type 2 diabetes and obesity.

What is Compounded Tirzepatide?

Compounding is the process of creating a medication that’s tailored to the needs of an individual patient. For example, some patients may need a medication in liquid form when the FDA-approved drug comes in a pill. Additionally, a pharmacy can compound medications of FDA-approved drugs that are in shortage.

Compounded drugs are prepared by state-licensed compounding pharmacies that meet FDA and state requirements, including quality standards. When compounding in compliance with federal law, compounded drugs are not subject to FDA approval and do not have to undergo safety, effectiveness, or manufacturing review.

YBYC is partnering with compounding pharmacies to offer compounded tirzepatide that uses the same active ingredient as Mounjaro and Zepbound.

Benefits of Tirzepatide

Glycemic Control: Tirzepatide has demonstrated superior glycemic control compared to existing treatments, with significant reductions in HbA1c levels and fasting plasma glucose.

Weight Management: In addition to its glucose-lowering effects, tirzepatide has shown remarkable weight loss benefits, making it a promising option for individuals with obesity.

Cardiovascular Benefits: Preliminary research suggests potential cardiovascular benefits of tirzepatide, including a reduction in the risk of major adverse cardiovascular events in individuals with type 2 diabetes and established cardiovascular disease.

How to take Compounded Tirzepatide

Tirzepatide is injected under the skin, no more than once weekly at any time of the day, with or without food. Inject the medication on the same day of each week. Unlike the brand name medications, compounded tirzepatide is prefilled in small syringes and needles. All materials needed will be provided.

Tirzepatide dosage is designed to gradually increase over time to minimize side effects. Currently, compounded tirzepatide is available in 2.5 mg, 5 mg, 7.5mg, 10 mg, 12.5mg and 15mg. You must stay at each dose for at least four weeks.

General instructions may include:

• Store the tirzepatide in its original packaging in a refrigerator.
• Remember to label the date you opened the medication since it’s only suitable for 28 days after opening.
• Position the needle at a 90-degree angle, straight up and down, and carefully insert it into the injection site (subcutaneous injections are primarily injected into the abdomen or optionally the upper/outer thigh)
• Gradually press down the plunger until it reaches the bottom, and then withdraw the needle gently.
• Safely dispose of the used needle and syringe using a sharps disposal container.

What are the side effects of Tirzepatide?
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.

Common side effects of tirzepatide include nausea, vomiting, diarrhea, and constipation. In some cases, individuals may experience decreased appetite, which contributes to the weight loss effects of the medication.

Tirzepatide may carry a risk of pancreatitis, particularly in individuals with a history of pancreatitis. Additionally, there is a potential risk of thyroid C-cell tumors, which has been observed in animal studies. It is important to carefully consider these potential risks when prescribing tirzepatide.